Reflections on the 2025 Sanofi Patient Advocacy Council
Pictured left to right: Jeff Schaffnit, Phil Gattone, Kim Phelan, Dawn Rotellini, Jane Cavanaugh Smith, and Dan Kelsey
BY KIM PHELAN
Reflections on the 2025 Sanofi Patient Advocacy Council
Attending the 2025 Sanofi Patient Advocacy Council held in Washington DC February 18-19 2025, was an incredible experience, bringing together advocacy leaders from across multiple therapeutic areas to collaborate on the shared goal of improving patient access to care. It was truly inspiring to reconnect with familiar faces from the hemophilia community while also forging new relationships with advocates from other disease states.
The synergy throughout the event was remarkable. Engaging in meaningful discussions with Sanofi leadership and fellow advocacy executives reinforced the importance of collective action in shaping healthcare policy, advancing research, and ensuring patients have access to innovative treatments.
I am grateful for the opportunity to participate in this dynamic exchange of ideas and look forward to continuing these important conversations in the year ahead. I can’t wait to attend again next year!